Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema
- PMID: 25821815
- PMCID: PMC4363610
- DOI: 10.1155/2015/646853
Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema
Abstract
Meningiomas constitute up to 13% of all intracranial tumors. The predictive factors for meningioma have not been unambiguously defined; however some limited data suggest that the expression of matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) may be associated with the presence of peritumoral brain edema (PTBE) and worse clinical outcome. The aim of this study was to analyze the expressions of MMP-9 and VEGF in a group of meningiomas of various grades and to study associations between these two markers and PTBE. The study included patients with supratentorial meningiomas. The patients were divided into low- (G1) and high-grade meningiomas (G2 and G3). PTBE was assessed on MRI. The expressions of VEGF and MMP-9 were determined immunohistochemically. The expression of MMP-9 was observed significantly more often in G3 meningiomas than in lower grade tumors. The presence of stage II or III PTBE was associated with a significant increase in MMP-9 expression. The expression of VEGF did not differ across the PTBE stages. Our findings point to a significant role of MMP-9 and VEGF in the pathogenesis of peritumoral brain edema in low- and high-grade meningiomas.
Figures



Similar articles
-
Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.Dan Med J. 2013 Apr;60(4):B4626. Dan Med J. 2013. PMID: 23651727 Review.
-
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas.Neuropathology. 2012 Dec;32(6):638-46. doi: 10.1111/j.1440-1789.2012.01312.x. Epub 2012 Mar 15. Neuropathology. 2012. PMID: 22420586
-
Vascular endothelial growth factor A protein level and gene expression in intracranial meningiomas with brain edema.APMIS. 2011 Dec;119(12):831-43. doi: 10.1111/j.1600-0463.2011.02764.x. Epub 2011 Oct 17. APMIS. 2011. PMID: 22085359
-
Correlation of clinical and biological parameters with peritumoral edema in meningioma.J Neurooncol. 2002 Dec;60(3):235-45. doi: 10.1023/a:1021186401522. J Neurooncol. 2002. PMID: 12510775
-
Peritumoral edema in meningiomas: pathophysiology, predictors, and principles for treatment.Clin Transl Oncol. 2023 Apr;25(4):866-872. doi: 10.1007/s12094-022-03009-0. Epub 2022 Nov 24. Clin Transl Oncol. 2023. PMID: 36427121 Review.
Cited by
-
Vascular endothelial growth factor concentrations in the cerebrospinal fluid of dogs with neoplastic or inflammatory central nervous system disorders.J Vet Intern Med. 2021 Jul;35(4):1873-1883. doi: 10.1111/jvim.16181. Epub 2021 Jun 9. J Vet Intern Med. 2021. PMID: 34105831 Free PMC article.
-
Shenqi Fuzheng Injection (SFI) Enhances IFN-α Inhibitory Effect on Hepatocellular Carcinoma Cells by Reducing VEGF Expression: Validation by Gene Silencing Technique.Biomed Res Int. 2019 Apr 23;2019:8084109. doi: 10.1155/2019/8084109. eCollection 2019. Biomed Res Int. 2019. PMID: 31179333 Free PMC article.
-
Clinical and histopathological predictors of outcome in malignant meningioma.Neurosurg Rev. 2020 Apr;43(2):643-653. doi: 10.1007/s10143-019-01093-5. Epub 2019 Mar 13. Neurosurg Rev. 2020. PMID: 30868425
-
Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.Curr Oncol. 2021 Apr 18;28(2):1537-1543. doi: 10.3390/curroncol28020145. Curr Oncol. 2021. PMID: 33919580 Free PMC article.
-
Recent Advances in Meningioma Immunogenetics.Front Oncol. 2020 Jan 8;9:1472. doi: 10.3389/fonc.2019.01472. eCollection 2019. Front Oncol. 2020. PMID: 31970090 Free PMC article. Review.
References
-
- Barresi V., Alafaci C., Caffo M., Barresi G., Tuccari G. Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas. Pathology Research and Practice. 2012;208(6):350–355. doi: 10.1016/j.prp.2012.02.013. - DOI - PubMed
-
- Beltran E., Matiasek K., de Risio L., de Stefani A., Feliu-Pascual A. L., Matiasek L. A. Expression of MMP-2 and MMP-9 in benign canine rostrotentorial meningiomas is not correlated to the extent of peritumoral edema. Veterinary Pathology. 2013;50(6):1091–1098. doi: 10.1177/0300985813481610. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous